Prefrontal Dysfunction in Schizophrenia Involves Mixed-Lineage Leukemia 1-Regulated Histone Methylation at GABAergic Gene Promoters
Open accessAbstract
Alterations in GABAergic mRNA expression play a key role for prefrontal dysfunction in schizophrenia and other neurodevelopmental disease. Here, we show that histone H3-lysine 4 methylation, a chromatin mark associated with the transcriptional process, progressively increased at GAD1 and other GABAergic gene promoters ( GAD2 , NPY , SST ) in human prefrontal cortex (PFC) from prenatal to peripubertal ages and throughout adulthood. Alterations in schizophrenia included decreased GAD1 expression and H3K4-trimethylation, predominantly in females and in conjunction with a risk haplotype at the 5′ end of GAD1 . Heterozygosity for a truncated, lacZ knock-in allele of mixed-lineage leukemia 1 ( Mll1 ), a histone methyltransferase expressed in GABAergic and other cortical neurons, resulted in decreased H3K4 methylation at GABAergic gene promoters. In contrast, Gad1 H3K4 (tri)methylation and Mll1 occupancy was increased in cerebral cortex of mice after treatment with the atypical antipsychotic, clozapine. These effects were not mimicked by haloperidol or genetic ablation of dopamine D 2 and D 3 receptors, suggesting that blockade of D 2 -like signaling is not sufficient for clozapine-induced histone methylation. Therefore, chromatin remodeling mechanisms at GABAergic gene promoters, including MLL1-mediated histone methylation, operate throughout an extended period of normal human PFC development and play a role in the neurobiology of schizophrenia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Given the role of histone methylation in establishing active promoters, it appears likely that dysregulation of histone methylation may have downstream effects with the potential to disrupt neurodevelopment and coordinated gene expression, as animal studies have demonstrated.
“Given the role of this process in establishing active promoters38, it appears likely that the dysregulation of histone methylation may have downstream effects with the potential to disrupt neurodevelopment and coordinated gene expression, as animal studies have demonstrated39.”
From Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) · cites this paper as [39]
Cites
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724 · see citing works
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 1× · see citing works
“Next, we monitored levels of H3K4me3, and of H3-mono-methyl-lysine 4 (H3K4me1) [a related modification that partially overlaps with H3K4me3 in genome-wide screens (Heintzman et al., 2007)] around GAD1 TSS during the course of PFC development.”
MethodGenomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse
Bernstein, B., Kamal, M., Lindblad‐Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., Gingeras, T., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.001 · Cited by 1,509 · see citing works
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · see citing works
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D. Y., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,051 · see citing works
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002 · see citing works
Self-citationAltered Hox expression and segmental identity in Mll-mutant mice
Yu, B., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 872 · see citing works
Histone H3 lysine 4 methylation patterns in higher eukaryotic genes
Schneider, R., Bannister, A. J., Myers, F. A., Thorne, A. W., Crane‐Robinson, C., & Kouzarides, T. (2003) · Nature Cell Biology · doi:10.1038/ncb1076 · Cited by 792 · see citing works
Histone lysine methylation: a signature for chromatin function
Sims, R. J., Nishioka, K., & Reinberg, D. (2003) · Trends in Genetics · doi:10.1016/j.tig.2003.09.007 · Cited by 684 · see citing works
Lieberman, J. A., Perkins, D. O., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593 · see citing works
Reelin promoter hypermethylation in schizophrenia
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553 · see citing works
The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation
Tahiliani, M., Mei, P., Fang, R., Leonor, T., Rutenberg, M. S., Shimizu, F., Li, J., Rao, A., & Shi, Y. G. (2007) · Nature · doi:10.1038/nature05823 · Cited by 429 · see citing works
Global and Hox-specific roles for the MLL1 methyltransferase
Guenther, M. G., Jenner, R. G., Chevalier, B. S., Nakamura, T., Croce, C. M., Canaani, E., & Young, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503072102 · Cited by 357 · see citing works
Heckers, S., Stone, D., Walsh, J., Shick, J., Koul, P., & Benes, F. M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.521 · Cited by 322 · see citing works
Pathophysiologically based treatment interventions in schizophrenia
Lewis, D. A., & González‐Burgos, G. (2006) · Nature Medicine · doi:10.1038/nm1478 · Cited by 320 · see citing works
Hampsey, M., & Reinberg, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00360-x · Cited by 309 · see citing works
Yu, B., Hanson, R. D., Hess, J. L., Horning, S. E., & Korsmeyer, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10632 · Cited by 302 · see citing works
Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia
Lipska, B. K., Deep‐Soboslay, A., Weickert, C. S., Hyde, T. M., Martin, C. E., Herman, M. M., & Kleinman, J. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.019 · Cited by 281 · see citing works
Straub, R. E., Lipska, B. K., Egan, M. F., Goldberg, T. E., Callicott, J. H., Mayhew, M. B., Vakkalanka, R., Kolachana, B. S., Kleinman, J. E., & Weinberger, D. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001988 · Cited by 275 · see citing works
In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
Veldić, M., Guidotti, A., Maloku, E., Davis, J. M., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409665102 · Cited by 269 · see citing works
Immunoprecipitation of native chromatin: NChIP.
O'Neill, L., & Turner, B. (2003) · Methods · doi:10.1016/s1046-2023(03)00090-2 · Cited by 239 · see citing works
MLL associates specifically with a subset of transcriptionally active target genes
Milne, T. A., Dou, Y., Martin, M. E., Brock, H. W., Roeder, R. G., & Hess, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503630102 · Cited by 230 · see citing works
The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis
Petronis, A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.005 · Cited by 225 · see citing works
GAD1 mRNA Expression and DNA Methylation in Prefrontal Cortex of Subjects with Schizophrenia
Huang, H., & Akbarian, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000809 · Cited by 223 · see citing works
Self-citationAbdolmaleky, H. M., Smith, C. L., Faraone, S. V., Shafa, R., Stone, W., Glatt, S. J., & Tsuang, M. T. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20142 · Cited by 216 · see citing works
Addington, A. M., Gornick, M., Duckworth, J., Sporn, A. L., Gogtay, N., Bobb, A., GREENSTEIN, D. K., Lenane, M., Gochman, P., Baker, N., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001599 · Cited by 207 · see citing works
What's atypical about atypical antipsychotic drugs?
Meltzer, H. Y. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.09.010 · Cited by 199 · see citing works
Hettema, J. M., An, S., Neale, M. C., Bukszár, J., van den Oord, E. J. C. G., Kendler, K. S., & Chen, X. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001845 · Cited by 175 · see citing works
The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells
Laeng, P., Pitts, R. L., Lemire, A. L., Drabik, C. E., Weiner, A., Tang, H., Thyagarajan, R., Mallon, B. S., & Altar, C. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02725.x · Cited by 169 · see citing works
Yokoyama, A., Kitabayashi, I., Ayton, P. M., Cleary, M. L., & Ohki, M. (2002) · Blood · doi:10.1182/blood-2002-04-1015 · Cited by 161 · see citing works
Akbarian, S., Ruehl, M. G., Bliven, E. E., Luiz, L. A., Peranelli, A. C., Baker, S. P., Roberts, R. C., Bunney, W. E., Conley, R. C., Jones, E. G., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.829 · Cited by 140 · see citing works
Self-citationHettema, J. M., An, S., Neale, M. C., Bukszár, J., van den Oord, E. J. C. G., Kendler, K. S., & Chen, X.-X. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001858 · Cited by 137 · see citing works
Activity-dependent Changes in GAD and Preprotachykinin mRNAs in Visual Cortex of Adult Monkeys
Benson, D. L., Huntsman, M. M., & Jones, E. G. (1994) · Cerebral Cortex · doi:10.1093/cercor/4.1.40 · Cited by 133 · see citing works
Pillai-Nair, N., Panicker, A. K., Rodriguiz, R. M., Gilmore, K. L., Demyanenko, G. P., Huang, Z. J., Wetsel, W. C., & Maness, P. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0565-05.2005 · Cited by 125 · see citing works
Lewis, D. A., Cruz, D. A., Eggan, S. M., & Erickson, S. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1308.008 · Cited by 121 · see citing works
Mice Lacking Dopamine D2and D3Receptors Have Spatial Working Memory Deficits
Glickstein, S. B., Hof, P. R., & Schmauss, C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05619.2002 · Cited by 119 · see citing works
Lipska, B. K., Lerman, D. N., Khaing, Z. Z., Weickert, C. S., & Weinberger, D. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02738.x · Cited by 104 · see citing works
Chromatin immunoprecipitation in postmortem brain
Huang, H., Matevossian, A., Jiang, Y. P., & Akbarian, S. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.02.018 · Cited by 96 · see citing works
Self-citationKim, S. Y., Levenson, J. M., Korsmeyer, S. J., Sweatt, J. D., & Schumacher, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608722200 · Cited by 71 · see citing works
Self-citationLeaving a mark: the many footprints of the elongating RNA polymerase II
Eissenberg, J. C., & Shilatifard, A. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.02.004 · Cited by 66 · see citing works
Zink, M., Schmitt, A., May, B., Müller, B., Demirakça, T., Braus, D. F., & Henn, F. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00088-4 · Cited by 61 · see citing works
Lundorf, M. D., Buttenschøn, H. N., Foldager, L., Blackwood, D. H. R., Muir, W. J., Murray, V., Pelosi, A. J., Kruse, T. A., Ewald, H., & Mors, O. N. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30137 · Cited by 53 · see citing works
Chertkow, Y., Weinreb, O., Youdim, M. B. H., & Silver, H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005626 · Cited by 39 · see citing works
Gao, W. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00400.2006 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,949 · see citing works
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium (2015) · Nature Neuroscience · doi:10.1038/nn.3922 · Cited by 755 · see citing works
González‐Burgos, G., & Lewis, D. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn070 · Cited by 568 · see citing works
Histone Methylation Regulates Memory Formation
Gupta, S., Kim, S. Y., Artis, S., Molfese, D. L., Schumacher, A., Sweatt, J. D., Paylor, R. E., & Lubin, F. D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3732-09.2010 · Cited by 562 · see citing works
Self-citationEpigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders
Abel, T. G., & Zukin, R. S. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.002 · Cited by 495 · see citing works
Epigenetic basis of mental illness
Nestler, E. J., Peña, C. J., Kundakovic, M., Mitchell, A., & Akbarian, S. (2016) · The Neuroscientist · doi:10.1177/1073858415608147 · Cited by 342 · see citing works
Self-citationHyde, T. M., Lipska, B. K., Ali, T., Mathew, S., Law, A. J., Metitiri, O. E., Straub, R. E., Ye, T., Colantuoni, C., Herman, M. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1234-11.2011 · Cited by 325 · see citing works
The role of histone modifications: from neurodevelopment to neurodiseases
Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 321 · see citing works
Epigenetic principles and mechanisms underlying nervous system functions in health and disease
Mehler, M. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 292 · see citing works
Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation
Dong, E., Nelson, M., Grayson, D. R., Costa, E., & Guidotti, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805493105 · Cited by 284 · see citing works
Mellios, N., Huang, H.-S., Grigorenko, A., Rogaev, E., & Akbarian, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn201 · Cited by 239 · see citing works
Self-citationThe Dynamics of DNA Methylation in Schizophrenia and Related Psychiatric Disorders
Grayson, D. R., & Guidotti, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.125 · Cited by 267 · see citing works
Mellios, N., Huang, H.-S., Baker, S. P., Galdzicka, M., Ginns, E., & Akbarian, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.019 · Cited by 266 · see citing works
Self-citationAlterations of cortical GABA neurons and network oscillations in schizophrenia
Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0124-8 · Cited by 260 · see citing works
GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia
González‐Burgos, G., Fish, K. N., & Lewis, D. A. (2011) · Neural Plasticity · doi:10.1155/2011/723184 · Cited by 244 · see citing works
Cheung, I., Shulha, H. P., Jiang, Y., Matevossian, A., Wang, J., Weng, Z., & Akbarian, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001702107 · Cited by 235 · see citing works
Self-citationAn epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229 · see citing works
Epigenetic GABAergic targets in schizophrenia and bipolar disorder
Guidotti, A., Auta, J., Chen, Y., Davis, J. M., Dong, E., Gavin, D. P., Grayson, D. R., Matrisciano, F., Pinna, G., Satta, R., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.021 · Cited by 220 · see citing works
Ramazi, S., Allahverdi, A., & Zahiri, J. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00099-2 · Cited by 219 · see citing works
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects
Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1165-19.2019 · Cited by 218 · see citing works
Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia
Lewis, D. A. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.11.003 · Cited by 217 · see citing works
Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene
Takata, A., Xu, B., Ionita-Laza, I., Roos, J. L., Gogos, J. A., & Karayiorgou, M. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.043 · Cited by 204 · see citing works
Epigenetic Regulation in Human Brain—Focus on Histone Lysine Methylation
Akbarian, S., & Huang, H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.015 · Cited by 214 · see citing works
Self-citationEpigenetics in the Nervous System: Figure 1.
Jiang, Y., Langley, B. C., Lubin, F. D., Renthal, W. R., Wood, M. A., Yasui, D. H., Kumar, A., Nestler, E. J., Akbarian, S., & Beckel-Mitchener, A. C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3797-08.2008 · Cited by 214 · see citing works
Self-citationFukuchi, M., Nii, T., Ishimaru, N., Minamino, A., Hara, D., Takasaki, I., Tabuchi, A., & Tsuda, M. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.05.002 · Cited by 202 · see citing works
Epigenetic Signatures of Autism: Trimethylated H3K4 Landscapes in Prefrontal Neurons
Shulha, H. P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.151 · Cited by 196 · see citing works
Richetto, J., & Meyer, U. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.008 · Cited by 183 · see citing works
Isolation of neuronal chromatin from brain tissue
Jiang, Y., Matevossian, A., Huang, H.-S., Straubhaar, J., & Akbarian, S. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-42 · Cited by 193 · see citing works
Self-citationSmigielski, L., Jagannath, V., Rössler, W., Walitza, S., & Grünblatt, E. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0601-3 · Cited by 168 · see citing works
Epigenetic mechanisms in schizophrenia
Roth, T. L., Lubin, F. D., Sodhi, M., & Kleinman, J. E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.009 · Cited by 168 · see citing works
The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain
Lee, S. E., Lee, Y., & Lee, G. H. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01196-z · Cited by 171 · see citing works
Regulation of histone H3K4 methylation in brain development and disease
Shen, E., Shulha, H. P., Weng, Z., & Akbarian, S. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0514 · Cited by 165 · see citing works
Self-citationEpigenetic dysregulation in cognitive disorders
Gräff, J., & Mansuy, I. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06787.x · Cited by 163 · see citing works
Jakovcevski, M., Ruan, H., Shen, E. Y., Dincer, A., Javidfar, B., Ma, Q., Peter, C., Cheung, I. K., Mitchell, A., Jiang, Y., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3004-14.2015 · Cited by 138 · see citing works
Self-citationGABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia
Xu, M., & Wong, A. H. C. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.172 · Cited by 159 · see citing works
Deficits in Transcriptional Regulators of Cortical Parvalbumin Neurons in Schizophrenia
Volk, D. W., Matsubara, T., Li, S., Sengupta, E. J., Георгиев, Д., Minabe, Y., Sampson, A. R., Hashimoto, T., & Lewis, D. A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030305 · Cited by 155 · see citing works
Glausier, J. R., Fish, K. N., & Lewis, D. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.152 · Cited by 147 · see citing works
Kundaković, M., Chen, Y., Guidotti, A., & Grayson, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051763 · Cited by 149 · see citing works
Hoftman, G. D., Volk, D. W., Bazmi, H. H., Li, S., Sampson, A. R., & Lewis, D. A. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt178 · Cited by 146 · see citing works
Davis, J., Moylan, S., Harvey, B. H., Maes, M. H. J., & Berk, M. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414533012 · Cited by 147 · see citing works
Ratnu, V. S., Emami, M. R., & Bredy, T. W. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23886 · Cited by 144 · see citing works
Delgado‐Morales, R., Agís‐Balboa, R. C., Esteller, M., & Berdasco, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0365-z · Cited by 143 · see citing works
Miller, M. L., Chadwick, B., Dickstein, D. L., Purushothaman, I., Egervari, G., Rahman, T., Tessereau, C., Hof, P. R., Roussos, P., Shen, L., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0243-x · Cited by 134 · see citing works
Perišić, T., Zimmermann, N., Kirmeier, T., Asmus, M., Tuorto, F., Uhr, M., Holsboer, F., Rein, T., & Zschocke, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.188 · Cited by 133 · see citing works
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
Lally, J., Gaughran, F., Timms, P. W., & Curran, S. R. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s115741 · Cited by 131 · see citing works
Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling
Guidotti, A., Dong, E., Kundakovic, M., Satta, R., Grayson, D. R., & Costa, E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.010 · Cited by 130 · see citing works
Histone modifications, DNA methylation, and Schizophrenia
Gavin, D. P., & Sharma, R. P. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.010 · Cited by 121 · see citing works
Jiang, Y., Jakovcevski, M., Bharadwaj, R., Connor, C., Schroeder, F. A., Lin, C. L., Straubhaar, J., Martin, G., & Akbarian, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1314-10.2010 · Cited by 118 · see citing works
Self-citationEpigenetics-beyond the genome in alcoholism.
Starkman, B. G., Sakharkar, A. J., & Pandey, S. C. (2012) · Europe PMC (PubMed Central) · Cited by 118 · see citing works
Epigenetic approaches to psychiatric disorders
Ptak, C., & Petronis, A. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/cptak · Cited by 118 · see citing works
Hoftman, G. D., Datta, D., & Lewis, D. A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.022 · Cited by 109 · see citing works
Balancing histone methylation activities in psychiatric disorders
Peter, C. J., & Akbarian, S. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.02.003 · Cited by 110 · see citing works
Self-citationEpigenomic Dysregulation in Schizophrenia: In Search of Disease Etiology and Biomarkers
Khavari, B., & Cairns, M. J. (2020) · Cells · doi:10.3390/cells9081837 · Cited by 106 · see citing works
Growth Arrest and DNA-Damage-Inducible, Beta (GADD45b)-Mediated DNA Demethylation in Major Psychosis
Gavin, D. P., Sharma, R. P., Chase, K. A., Matrisciano, F., Dong, E., & Guidotti, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.221 · Cited by 104 · see citing works
Epigenetics of major psychosis: progress, problems and perspectives
Labrie, V., Pai, S., & Petronis, A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.04.002 · Cited by 102 · see citing works
Ruzicka, W. B., Subburaju, S., & Benes, F. M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.49 · Cited by 101 · see citing works
Bulik, C. M., Blake, L. E., & Austin, J. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2018.10.007 · Cited by 117 · see citing works
Connor, C., Dincer, A., Straubhaar, J., Galler, J. R., Houston, I. B., & Akbarian, S. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.037 · Cited by 100 · see citing works
Self-citationHormetic Nutrition and Redox Regulation in Gut–Brain Axis Disorders
Scuto, M. C., Rampulla, F., Reali, G. M., Spanò, S. M., Salinaro, A. T., & Calabrese, V. (2024) · Antioxidants · doi:10.3390/antiox13040484 · Cited by 98 · see citing works
Epigenetic impacts of endocrine disruptors in the brain
Walker, D. M., & Gore, A. C. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.09.002 · Cited by 94 · see citing works
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
Snyder, M. A., & Gao, W. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.010 · Cited by 93 · see citing works
White matter neuron alterations in schizophrenia and related disorders
Connor, C., Crawford, B. C., & Akbarian, S. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.07.236 · Cited by 92 · see citing works
Self-citationEpigenetic Determinants of Healthy and Diseased Brain Aging and Cognition
Akbarian, S., Beeri, M. S., & Haroutunian, V. H. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1459 · Cited by 93 · see citing works
Self-citationMarinova, Z., Leng, Y., Leeds, P. R., & Chuang, D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.022 · Cited by 91 · see citing works
Epigenetic Impacts on Neurodevelopment: Pathophysiological Mechanisms and Genetic Modes of Action
Zahir, F., & Brown, C. J. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318213565e · Cited by 93 · see citing works
Kimoto, S., Bazmi, H. H., & Lewis, D. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010004 · Cited by 91 · see citing works
Shen, E., Ahern, T. H., Cheung, I. K., Straubhaar, J., Dincer, A., Houston, I. B., Vries, G. J. D., Akbarian, S., & Forger, N. G. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.006 · Cited by 91 · see citing works
Self-citationDNA methylation in schizophrenia: progress and challenges of epigenetic studies
Nishioka, M., Bundo, M., Kasai, K., & Iwamoto, K. (2012) · Genome Medicine · doi:10.1186/gm397 · Cited by 90 · see citing works
Current status and future prospects for epigenetic psychopharmacology
Boks, M. P., de Jong, N. M., Kas, M. J. H., Vinkers, C. H., Fernandes, C., Kahn, R. S., Mill, J., & Ophoff, R. A. (2012) · Epigenetics · doi:10.4161/epi.7.1.18688 · Cited by 89 · see citing works
Aguilar‐Valles, A., Vaissière, T., Griggs, E. M., Mikaelsson, M. A., Takács, I. F., Young, E. J., Rumbaugh, G., & Miller, C. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.014 · Cited by 89 · see citing works
Jiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 89 · see citing works
Kano, S., Colantuoni, C., Han, F., Zhou, Z., Yuan, Q., Wilson, A., Takayanagi, Y., Lee, Y., Rapoport, J. L., Eaton, W. W., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.120 · Cited by 88 · see citing works
Translational potential of olfactory mucosa for the study of neuropsychiatric illness
Borgmann‐Winter, K. E., Willard, S. L., Sinclair, D., Mirza, N. A., Turetsky, B. I., Berretta, S., & Hahn, C.-G. (2015) · Translational Psychiatry · doi:10.1038/tp.2014.141 · Cited by 89 · see citing works
Delays in GABAergic interneuron development and behavioral inhibition after prenatal stress
Lussier, S. J., & Stevens, H. E. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22376 · Cited by 89 · see citing works
Epigenetic mechanisms in schizophrenia
Akbarian, S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/sakbarian · Cited by 89 · see citing works
Self-citationNagahama, K., Sakoori, K., Watanabe, T., Kishi, Y., Kawaji, K., Koebis, M., Nakao, K., Gotoh, Y., Aiba, A., Uesaka, N., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108126 · Cited by 94 · see citing works
Dienel, S. J., Schoonover, K. E., & Lewis, D. A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.03.002 · Cited by 81 · see citing works
DNA methylation changes in schizophrenia and bipolar disorder
Connor, C., & Akbarian, S. (2008) · Epigenetics · doi:10.4161/epi.3.2.5938 · Cited by 84 · see citing works
Self-citationBroad domains of histone H3 lysine 4 trimethylation in transcriptional regulation and disease
Park, S., Kim, G. W., Kwon, S. H., & Lee, J. (2020) · FEBS Journal · doi:10.1111/febs.15219 · Cited by 83 · see citing works
Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders
Guidotti, A., Grayson, D. R., & Caruncho, H. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00089 · Cited by 83 · see citing works
Environmental regulation of the neural epigenome
Caldji, C., Hellstrom, I. C., Zhang, T.-Y., Diorio, J., & Meaney, M. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.032 · Cited by 82 · see citing works
Sex Differences in Brain Epigenetics
Menger, Y., Bettscheider, M., Murgatroyd, C., & Spengler, D. (2010) · Epigenomics · doi:10.2217/epi.10.60 · Cited by 82 · see citing works
Spatial genome organization and cognition
Rajarajan, P., Espeso‐Gil, S., Brennand, K., & Akbarian, S. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.124 · Cited by 80 · see citing works
Self-citationVečeřa, J., Bártová, E., Krejčí, J., Legartová, S., Komůrková, D., Kučerová, J., Štark, T., Dražanová, E., Kašpárek, T., Šulcová, A., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25914 · Cited by 80 · see citing works
Carlyle, B. C., Duque, A., Kitchen, R. R., Bordner, K. A., Coman, D., Doolittle, E., Papademetris, X., Hyder, F., Taylor, J. R., & Simen, A. A. (2012) · Development and Psychopathology · doi:10.1017/s095457941200079x · Cited by 80 · see citing works
Lubin, F. D., Gupta, S., Parrish, R. R., Grissom, N. M., & Davis, R. L. (2011) · The Neuroscientist · doi:10.1177/1073858411386967 · Cited by 97 · see citing works
Dong, E., Tueting, P. A., Matrisciano, F., Grayson, D. R., & Guidotti, A. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.191 · Cited by 80 · see citing works
Sensitive Periods in Epigenetics: Bringing us Closer to Complex Behavioral Phenotypes
Nagy, C., & Turecki, G. (2012) · Epigenomics · doi:10.2217/epi.12.37 · Cited by 78 · see citing works
Bai, G., Cheung, I. K., Shulha, H. P., Coelho, J. E., Li, P., Dong, X., Jakovcevski, M., Wang, Y., Grigorenko, A. P., Jiang, Y. P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu561 · Cited by 76 · see citing works
Self-citationAn Update on the Epigenetics of Psychotic Diseases and Autism
Abdolmaleky, H. M., Zhou, J., & Thiagalingam, S. (2015) · Epigenomics · doi:10.2217/epi.14.85 · Cited by 75 · see citing works
Epigenetics in the Human Brain
Houston, I. B., Peter, C. J., Mitchell, A., Straubhaar, J., Rogaev, E. I., & Akbarian, S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.78 · Cited by 75 · see citing works
Self-citationGender-Specific Reduction of Estrogen-Sensitive Small RNA, miR-30b, in Subjects With Schizophrenia
Mellios, N., Galdzicka, M. M., Ginns, E. I., Baker, S. P., Rogaev, E. I., Xu, J., & Akbarian, S. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq091 · Cited by 75 · see citing works
Self-citationAbdolmaleky, H. M., Pajouhanfar, S., Faghankhani, M., Joghataei, M. T., Mostafavi, A., & Thiagalingam, S. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32361 · Cited by 73 · see citing works
Genetic Modulation of GABA Levels in the Anterior Cingulate Cortex by GAD1 and COMT
Marenco, S., Farmer, A. S., van der Veen, J. W. C., Geramita, M. A., Stern, A., Barnett, A. S., Kolachana, B. S., Radulescu, E., Zhang, F., Callicott, J. H., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.35 · Cited by 71 · see citing works
Shulha, H. P., Cheung, I. K., Guo, Y., Akbarian, S., & Weng, Z. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003433 · Cited by 72 · see citing works
Self-citationHistone lysine methylation: critical regulator of memory and behavior
Jarome, T. J., & Lubin, F. D. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0008 · Cited by 70 · see citing works
Dincer, A., Gavin, D. P., Xu, K., Zhang, B., Dudley, J. T., Schadt, E. E., & Akbarian, S. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.169 · Cited by 65 · see citing works
Self-citationUnderstanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy
Swathy, B., & Banerjee, M. (2017) · Epigenomics · doi:10.2217/epi-2016-0106 · Cited by 69 · see citing works
Matrisciano, F., Dong, E., Gavin, D. P., Nicoletti, F., & Guidotti, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070896 · Cited by 68 · see citing works
van de Leemput, J., Hess, J., Glatt, S. J., & Tsuang, M. T. (2016) · Advances in genetics · doi:10.1016/bs.adgen.2016.08.001 · Cited by 68 · see citing works
- Authors
- Huang, H.-S., Matevossian, A., Whittle, C., Kim, S. Y., Schumacher, A., Baker, S. P., & Akbarian, S.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Baylor College of Medicine (US)
- Corresponding author
- Akbarian, Schahram
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-10-17
- Volume
- 27
- Issue
- 42
- Pages
- 11254-11262
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6673022
- OpenAlex
- W2124607109
- Cited by
- 352
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 13 · 2023: 14 · 2022: 19 · 2021: 15 · 2020: 13 · 2019: 12 · 2018: 15 · 2017: 10 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 25
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute of Mental Health
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- schizophrenia, prefrontal cortex, MLL1, histone H3 lysine 4 methylation, GABAergic neurons, GAD1, promoter, chromatin remodeling, clozapine, dopamine D2/D3 receptors, sex differences, brain development
- MeSH terms
- Adult, Animals, Cells, Cultured, Child, Female, gamma-Aminobutyric Acid, Glutamate Decarboxylase, Histones, Humans, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Promoter Regions, Genetic, Histone-Lysine N-Methyltransferase, Schizophrenia, Prefrontal Cortex, DNA Methylation, Mice, Rats, Myeloid-Lymphoid Leukemia Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review